Robert Matthew Strother

About

Robert Matthew Strother is a Senior Clinical Lecturer at the University of Otago Christchurch, New Zealand. His research primarily focuses on the survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitors and examining the assessment of fluoropyrimidine toxicity risk through various testing methods. He is committed to advancing the understanding of cancer treatments and their effects on patient health.